171
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Co-possession of phosphodiesterase type-5 inhibitors (PDE5-I) with nitrates

, , , , &
Pages 1451-1459 | Accepted 12 Mar 2010, Published online: 15 Apr 2010

References

  • Kloner RA, Zusman RM. Cardiovascular effects of sildenafil citrate and recommendations for its use. Am J Cardiol 1999;84:11-17N
  • Emmick JT, Stuewe SR, Mitchell M. Overview of the cardiovascular effects of tadalafil. Eur Heart J Supplements 2002;4:H32-47
  • Reffelmann T, Kloner RA. Vardenafil: a selective inhibitor of phosphdiesterase-5 for the treatment of erectile dysfunction. Expert Opin Pharmacother 2007;8:965-74
  • Reffelmann T, Kloner RA. Cardiovascular effects of phosphodiesterase 5 inhibitors. Curr Pharmaceutical Design 2006;12:3485-94
  • Kloner RA, Jackson G, Emmick JT, et al. Interaction between the phosphodiesterase 5 inhibitor, tadalafil, and the 2 a-blockers doxazosin and tamsulosin in healthy normotensive men. J Urol 2004;172:1935-40
  • Webb DJ, Muirhead GJ, Wulff M, et al. Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina. J Am Coll Cardiol 2000;36:25-31
  • Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 2003;89:251-3
  • Kostis JB, Jackson G, Rosen R, et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol 2005;96:313-21
  • Bacon CG, Hu FB, Giovannucci E, et al. Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care 2002;25:1458-63
  • Sefterl AD, Sun P, Swindle R. The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J Urol 2004;171:2341-5
  • Eng P, Ma M, Zhang X, et al. Codispensing of tadalafil and other phosphodiesterase type 5 inhibitors with contraindicated organic nitrates. Pharmacoepidemiol Drug Saf 2008;17:S1:246
  • Tobi H, Faber A, van den Berg PB, et al. Studying co-medication patterns: the impact of definitions. Pharmacoepidemiol Drug Saf 2007;16:405-11
  • Williams D, Feely J. Initial uptake in use of sildenafil in general practice. Eur J Clin Pharmacol 2001;56:911-14
  • Cheitlin MD, Hutter AM, Brindis RG, et al. Use of sildenafil (Viagra) in patients with cardiovascular disease. J Am Coll Cardiol 1999;33:273-82
  • Kloner RA, Hutter AM, Emmick JT, et al. Time course of the interaction between tadalafil and nitrates. J Am Coll Cardiol 2003;42:1855-60

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.